• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Astrazeneca COVID-19 vaccine effective against variants found in India

firstwordpharmaJune 23, 2021

Tag: AstraZeneca , COVID-19 , Vaccine

AstraZeneca, citing a study, said its COVID-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, as reported by U.S. News & World Report.

Astrazeneca COVID-19 vaccine effective against variants found in India

The University of Oxford study investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralize the variants.

An analysis by Public Health England (PHE) last week showed that vaccines developed by Pfizer and AstraZeneca offer protection of more than 90% against hospitalization from the Delta variant.

AstraZeneca said the latest results are built on the recent analysis by PHE.

Previous:Memos reveal internal FDA struggle over thorny Alzheimer's drug approval

Next:COVID-19 Vaccine Coverage in U.S. Highest Among ≥65-Year-Olds

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Astrazeneca COVID-19 vaccine effective against variants found in India | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral
Automatic GMP Washing and Drying System Meet Requirement of Pharmaceutical and Vaccine Production

Automatic GMP Washing and Drying System Meet Requirement of Pharmaceutical and Vaccine Production
Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production

Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production
Human Vaccine

Human Vaccine
B11 100ml amber plastic vaccine bottle

B11 100ml amber plastic vaccine bottle
Varicella Vaccine,Live (Vial)

Varicella Vaccine,Live (Vial)
500ml pp vaccine bottle manufacturer

500ml pp vaccine bottle manufacturer
Pet Vaccine Series

Pet Vaccine Series
Recombinant Hepatitis B Vaccine

Recombinant Hepatitis B Vaccine
Animal Vaccine Filling Line

Animal Vaccine Filling Line

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service